Puig, N.; Corchete-Sánchez, L.A.; Pérez-Morán, J.J.; Dávila, J.; PaÃno, T.; de la Rubia, J.; Oriol, A.; MartÃn-Sánchez, J.; de Arriba, F.; Bladé, J.;
et al. Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial. Cancers 2020, 12, 3615.
https://doi.org/10.3390/cancers12123615
AMA Style
Puig N, Corchete-Sánchez LA, Pérez-Morán JJ, Dávila J, PaÃno T, de la Rubia J, Oriol A, MartÃn-Sánchez J, de Arriba F, Bladé J,
et al. Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial. Cancers. 2020; 12(12):3615.
https://doi.org/10.3390/cancers12123615
Chicago/Turabian Style
Puig, NoemÃ, Luis A. Corchete-Sánchez, José J. Pérez-Morán, Julio Dávila, Teresa PaÃno, Javier de la Rubia, Albert Oriol, Jesús MartÃn-Sánchez, Felipe de Arriba, Joan Bladé,
and et al. 2020. "Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial" Cancers 12, no. 12: 3615.
https://doi.org/10.3390/cancers12123615
APA Style
Puig, N., Corchete-Sánchez, L. A., Pérez-Morán, J. J., Dávila, J., PaÃno, T., de la Rubia, J., Oriol, A., MartÃn-Sánchez, J., de Arriba, F., Bladé, J., Blanchard, M. -J., González-Calle, V., GarcÃa-Sanz, R., Paiva, B., Lahuerta, J. -J., San-Miguel, J. F., Mateos, M. -V., & Ocio, E. M.
(2020). Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial. Cancers, 12(12), 3615.
https://doi.org/10.3390/cancers12123615
